Telomeres and chromosomal translocations: There’s a ligase at the end of the translocation

Duncan M. Baird, Eric A. Hendrickson

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Chromosomal translocations are now well understood to not only constitute signature molecular markers for certain human cancers but often also to be causative in the genesis of that tumor. Despite the obvious importance of such events, the molecular mechanism of chromosomal translocations in human cells remains poorly understood. Part of the explanation for this dearth of knowledge is due to the complexity of the reaction and the need to archaeologically work backwards from the final product (a translocation) to the original unrearranged chromosomes to infer mechanism. Although not definitive, these studies have indicated that the aberrant usage of endogenous DNA repair pathways likely lies at the heart of the problem. An equally obfuscating aspect of this field, however, has also originated from the unfortunate species-specific differences that appear to exist in the relevant model systems that have been utilized to investigate this process. Specifically, yeast and murine systems (which are often used by basic science investigators) rely on different DNA repair pathways to promote chromosomal translocations than human somatic cells. In this chapter, we will review some of the basic concepts of chromosomal translocations and the DNA repair systems thought to be responsible for their genesis with an emphasis on underscoring the differences between other species and human cells. In addition, we will focus on a specific subset of translocations that involve the very end of a chromosome (a telomere). A better understanding of the relationship between DNA repair pathways and chromosomal translocations is guaranteed to lead to improved therapeutic treatments for cancer.

Original languageEnglish (US)
Title of host publicationAdvances in Experimental Medicine and Biology
PublisherSpringer New York LLC
Pages89-112
Number of pages24
DOIs
StatePublished - Jan 1 2018

Publication series

NameAdvances in Experimental Medicine and Biology
Volume1044
ISSN (Print)0065-2598
ISSN (Electronic)2214-8019

Fingerprint

Genetic Translocation
Telomere
Ligases
DNA Repair
Repair
DNA
Chromosomes
Cells
Neoplasms
Yeast
Tumors
Yeasts
Research Personnel

Keywords

  • A-NHEJ
  • C-NHEJ
  • Chromosomal translocations
  • DNA DSB Repair
  • HDR
  • LIGIII
  • LIGIV

Cite this

Baird, D. M., & Hendrickson, E. A. (2018). Telomeres and chromosomal translocations: There’s a ligase at the end of the translocation. In Advances in Experimental Medicine and Biology (pp. 89-112). (Advances in Experimental Medicine and Biology; Vol. 1044). Springer New York LLC. https://doi.org/10.1007/978-981-13-0593-1_7

Telomeres and chromosomal translocations : There’s a ligase at the end of the translocation. / Baird, Duncan M.; Hendrickson, Eric A.

Advances in Experimental Medicine and Biology. Springer New York LLC, 2018. p. 89-112 (Advances in Experimental Medicine and Biology; Vol. 1044).

Research output: Chapter in Book/Report/Conference proceedingChapter

Baird, DM & Hendrickson, EA 2018, Telomeres and chromosomal translocations: There’s a ligase at the end of the translocation. in Advances in Experimental Medicine and Biology. Advances in Experimental Medicine and Biology, vol. 1044, Springer New York LLC, pp. 89-112. https://doi.org/10.1007/978-981-13-0593-1_7
Baird DM, Hendrickson EA. Telomeres and chromosomal translocations: There’s a ligase at the end of the translocation. In Advances in Experimental Medicine and Biology. Springer New York LLC. 2018. p. 89-112. (Advances in Experimental Medicine and Biology). https://doi.org/10.1007/978-981-13-0593-1_7
Baird, Duncan M. ; Hendrickson, Eric A. / Telomeres and chromosomal translocations : There’s a ligase at the end of the translocation. Advances in Experimental Medicine and Biology. Springer New York LLC, 2018. pp. 89-112 (Advances in Experimental Medicine and Biology).
@inbook{94a33a69ec7242209321a54211c83a37,
title = "Telomeres and chromosomal translocations: There’s a ligase at the end of the translocation",
abstract = "Chromosomal translocations are now well understood to not only constitute signature molecular markers for certain human cancers but often also to be causative in the genesis of that tumor. Despite the obvious importance of such events, the molecular mechanism of chromosomal translocations in human cells remains poorly understood. Part of the explanation for this dearth of knowledge is due to the complexity of the reaction and the need to archaeologically work backwards from the final product (a translocation) to the original unrearranged chromosomes to infer mechanism. Although not definitive, these studies have indicated that the aberrant usage of endogenous DNA repair pathways likely lies at the heart of the problem. An equally obfuscating aspect of this field, however, has also originated from the unfortunate species-specific differences that appear to exist in the relevant model systems that have been utilized to investigate this process. Specifically, yeast and murine systems (which are often used by basic science investigators) rely on different DNA repair pathways to promote chromosomal translocations than human somatic cells. In this chapter, we will review some of the basic concepts of chromosomal translocations and the DNA repair systems thought to be responsible for their genesis with an emphasis on underscoring the differences between other species and human cells. In addition, we will focus on a specific subset of translocations that involve the very end of a chromosome (a telomere). A better understanding of the relationship between DNA repair pathways and chromosomal translocations is guaranteed to lead to improved therapeutic treatments for cancer.",
keywords = "A-NHEJ, C-NHEJ, Chromosomal translocations, DNA DSB Repair, HDR, LIGIII, LIGIV",
author = "Baird, {Duncan M.} and Hendrickson, {Eric A.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1007/978-981-13-0593-1_7",
language = "English (US)",
series = "Advances in Experimental Medicine and Biology",
publisher = "Springer New York LLC",
pages = "89--112",
booktitle = "Advances in Experimental Medicine and Biology",

}

TY - CHAP

T1 - Telomeres and chromosomal translocations

T2 - There’s a ligase at the end of the translocation

AU - Baird, Duncan M.

AU - Hendrickson, Eric A.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Chromosomal translocations are now well understood to not only constitute signature molecular markers for certain human cancers but often also to be causative in the genesis of that tumor. Despite the obvious importance of such events, the molecular mechanism of chromosomal translocations in human cells remains poorly understood. Part of the explanation for this dearth of knowledge is due to the complexity of the reaction and the need to archaeologically work backwards from the final product (a translocation) to the original unrearranged chromosomes to infer mechanism. Although not definitive, these studies have indicated that the aberrant usage of endogenous DNA repair pathways likely lies at the heart of the problem. An equally obfuscating aspect of this field, however, has also originated from the unfortunate species-specific differences that appear to exist in the relevant model systems that have been utilized to investigate this process. Specifically, yeast and murine systems (which are often used by basic science investigators) rely on different DNA repair pathways to promote chromosomal translocations than human somatic cells. In this chapter, we will review some of the basic concepts of chromosomal translocations and the DNA repair systems thought to be responsible for their genesis with an emphasis on underscoring the differences between other species and human cells. In addition, we will focus on a specific subset of translocations that involve the very end of a chromosome (a telomere). A better understanding of the relationship between DNA repair pathways and chromosomal translocations is guaranteed to lead to improved therapeutic treatments for cancer.

AB - Chromosomal translocations are now well understood to not only constitute signature molecular markers for certain human cancers but often also to be causative in the genesis of that tumor. Despite the obvious importance of such events, the molecular mechanism of chromosomal translocations in human cells remains poorly understood. Part of the explanation for this dearth of knowledge is due to the complexity of the reaction and the need to archaeologically work backwards from the final product (a translocation) to the original unrearranged chromosomes to infer mechanism. Although not definitive, these studies have indicated that the aberrant usage of endogenous DNA repair pathways likely lies at the heart of the problem. An equally obfuscating aspect of this field, however, has also originated from the unfortunate species-specific differences that appear to exist in the relevant model systems that have been utilized to investigate this process. Specifically, yeast and murine systems (which are often used by basic science investigators) rely on different DNA repair pathways to promote chromosomal translocations than human somatic cells. In this chapter, we will review some of the basic concepts of chromosomal translocations and the DNA repair systems thought to be responsible for their genesis with an emphasis on underscoring the differences between other species and human cells. In addition, we will focus on a specific subset of translocations that involve the very end of a chromosome (a telomere). A better understanding of the relationship between DNA repair pathways and chromosomal translocations is guaranteed to lead to improved therapeutic treatments for cancer.

KW - A-NHEJ

KW - C-NHEJ

KW - Chromosomal translocations

KW - DNA DSB Repair

KW - HDR

KW - LIGIII

KW - LIGIV

UR - http://www.scopus.com/inward/record.url?scp=85049372214&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049372214&partnerID=8YFLogxK

U2 - 10.1007/978-981-13-0593-1_7

DO - 10.1007/978-981-13-0593-1_7

M3 - Chapter

C2 - 29956293

AN - SCOPUS:85049372214

T3 - Advances in Experimental Medicine and Biology

SP - 89

EP - 112

BT - Advances in Experimental Medicine and Biology

PB - Springer New York LLC

ER -